Advancing precision synthetic biology to meet humankind’s greatest challenges + Jacob Vogan
Edmar Ferreira talks with Jacob Vogan, co-founder and Chief Scientific Officer of CB Therapeutics, where he designs and leads large projects to engineer microorganisms to produce high-value molecules, both natural and new-to-nature, for use in therapeutics, nutraceuticals, animal-free food, and more. Jacob and Sher started CB Therapeutics in their garage, and after several lab expansions and going through Y Combinator, the start-up is now housed in a 16,000 sq. ft state-of-the-art facility with a growing and experienced team outside San Diego, California.
In today’s episode, Jacob shared how the future looks like when CB Therapeutics is successful, the therapeutics that they developed, including the process that they have gone through upon producing their technology. Jacob shared about synthetic biology, their supply chain and compound, about the process of supplements. Jacob also shared his background, and how they started CB Therapeutics, Jacob also shared the lessons he learned from the markets. They also talked about mentors from their mental health technology, and how CB Therapeutics shows their progress with their investors. Find out Jacob’s message for everyone, and much more!
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.deeptechshow.com (https://www.deeptechshow.com?utm_medium=podcast&utm_campaign=CTA_1)
14 Feb 2023
Regenerative Liver Technologies + Dr.Eric Schuur
Edmar Ferreira talks with Dr.Eric Schuur, CEO and co-founder of HepaTx (https://hepatx.com/). He is a tenacious, creative innovator whose chief joy is bringing new ideas to life for patients suffering from difficult-to-treat diseases. Dr. Schuur has been innovating in the life science industry for 25 years and he has abundant start-up and emerging company experience with many early-stage companies, including Calydon, Inc. and Asthmatx, Inc.
Dr.Schuur shared how the future looks like when HepaTx is successful, how they started HepaTx, the idea behind creating HepaTx, and the technology that they are using to fix liver diseases including the transplant, he also shared the clinical trials that they made and about their first product in the upcoming year. Dr. Schuur also shared how their procedures work with HepaTx, the process, and the program that they go through with their technology. They also talked about the best advise from Dr.Schuur for any startup company, and much more!
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.deeptechshow.com (https://www.deeptechshow.com?utm_medium=podcast&utm_campaign=CTA_1)
10 Feb 2023
Creating next generation smart cell therapies + Scott Boyken
Edmar Ferreira talks with Scott Boyken, co-founder and CSO of Outpace Bio, which uses protein design to create mechanism-driven solutions that dramatically improve the efficacy and safety of cell and gene therapies. Scott created protein switches and logic gates capable of modularly controlling biological function in cells and precisely targeting immunotherapies, resulting in over 20 publications and the Burroughs Wellcome Fund Career Award at the Scientific Interface.
Scott shared how the future looks like when Outpace Bio is successful, he also shared the incredible interface of proteins and the designs that tailored cell therapy solutions through protein designs and custom programming, like cell therapies, especially for the anti-cancer and life cancer cells like leukemia. They also talked about the reason behind Outpace Bio uses the idea of functional protein designs and structures, nanotechnology, the methods of Outpace Bio in order to solve the problems, the biggest problem in microbiology, reversing the sequence of the protein designs, the methods they have in Outpace Bio, the enzymes designs that they have, and their amazing programs. Scott also tells us his life story of why he ended up working with protein designs and the new biology and much more!
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.deeptechshow.com (https://www.deeptechshow.com?utm_medium=podcast&utm_campaign=CTA_1)
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
4.5 / 5
4 ratings
Contact Deep Tech Show
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Deep Tech Show?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
